Kallikrein activates bradykinin B2 receptors in absence of kininogen.
about
Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitusA novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor.Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.Role of human tissue kallikrein in gastrointestinal stromal tumour invasion.Tissue kallikrein mediates pro-inflammatory pathways and activation of protease-activated receptor-4 in proximal tubular epithelial cells.Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines.Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formationNew insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.Kinin receptors as targets for cancer therapy.Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.Potentiation of Paclitaxel-Induced Pain Syndrome in Mice by Angiotensin I Converting Enzyme Inhibition and Involvement of Kinins.Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway.Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.Tissue kallikrein protects SH-SY5Y neuronal cells against oxygen and glucose deprivation-induced injury through bradykinin B2 receptor-dependent regulation of autophagy induction.
P2860
Q27348019-87830A89-6418-4DFF-9B8A-66533B5AF15EQ28541677-1FA83F21-74D7-4F68-B6A9-90772B3A4E50Q33615794-485C2C22-38D3-4498-A2D5-F02B83EE2A06Q33623829-DA7FF481-D74D-426B-B3B0-81C6C8D6A725Q34344121-841464D9-5F40-4B5C-A5ED-809B116073EAQ35106408-A61F6261-9F63-43C9-B2C5-E9D9E9C0C2AAQ35664924-1B9284B7-8764-4D69-BE71-9EE1CCABE9D2Q37201619-2F1413E1-744D-4575-AE31-FF97F295AF0FQ37217423-E050613B-506D-4B1C-839F-0D8D8A9DD5F9Q37235985-E2152E1D-8AE2-44F5-8BC5-DB75DA9B1A24Q37453804-A4F093FF-80E0-471E-8565-884D7E19DEE1Q37697813-38DD18AC-A21E-4832-9256-211A0A462F5EQ37984531-F34C3DF3-CFAF-48E5-8CBB-AA12AB8CFAB4Q38737293-9640BE48-0ED8-4881-B438-92EB1E792DF4Q39187514-4BA2653A-B9CC-4B51-BB3F-1B98BD3CF82CQ43060191-13B2E304-0854-43D0-8211-369F55830B9FQ46483686-E2AC59A8-6FFC-43A3-8AA8-001730ADDF99Q47870655-D4966236-3199-4139-90C5-9437F002ED96
P2860
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@ast
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@en
type
label
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@ast
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@en
prefLabel
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@ast
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@en
P2093
P2860
P1476
Kallikrein activates bradykinin B2 receptors in absence of kininogen.
@en
P2093
Claudie Hecquet
Dauren Biyashev
Ervin G Erdös
Fulong Tan
Peter A Deddish
Zhenlong Chen
P2860
P304
P356
10.1152/AJPHEART.00934.2005
P577
2005-11-04T00:00:00Z